Thrombotic complications and coagulopathy frequently occur in COVID-19. However, the
characteristics of COVID-19-associated coagulopathy (CAC) are distinct from those seen …

Sepsis is a complex syndrome with a high incidence, increasing by 8.7% annually over the
last 20 years. Coagulopathy is a leading factor associated with mortality in patients with …

This paper collates the pathological findings from initial published autopsy reports on 23
patients with coronavirus disease 2019 (COVID-19) from 5 centers in the United States of …

The novel coronavirus (“SARS-CoV-2”) outbreak has created a sense of panic globally and
has the medical community rapidly searching for answers. An estimated 100,000 individuals …

Objective To evaluate the therapeutic use of plasma exchange in COVID-19 patients
compared to controls. Methods A case series of critically ill adult men and non-pregnant …

Objectives: Coronavirus disease 2019 is caused by the novel severe acute respiratory
syndrome coronavirus 2 virus. Patients admitted to the ICU suffer from microvascular …

In this paper, a model is proposed of the pathophysiological processes of COVID-19 starting
from the infection of human type II alveolar epithelial cells (pneumocytes) by SARS-CoV-2 …

Sepsis is a life-threatening systemic illness attributed to a dysregulated host response to
infection. Sepsis is a global burden killing~ 11 million persons annually. In December 2019 …

Sepsis is a multifactorial syndrome primarily determined by the host response to an invading
pathogen. It is common, with over 48 million cases worldwide in 2017, and often lethal. The …

An analysis of published data appertaining to the cytokine storms of COVID-19, H1N1
influenza, cytokine release syndrome (CRS), and macrophage activation syndrome (MAS) …